251 related articles for article (PubMed ID: 15975926)
1. Roscovitine targets, protein kinases and pyridoxal kinase.
Bach S; Knockaert M; Reinhardt J; Lozach O; Schmitt S; Baratte B; Koken M; Coburn SP; Tang L; Jiang T; Liang DC; Galons H; Dierick JF; Pinna LA; Meggio F; Totzke F; Schächtele C; Lerman AS; Carnero A; Wan Y; Gray N; Meijer L
J Biol Chem; 2005 Sep; 280(35):31208-19. PubMed ID: 15975926
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of pyridoxal kinase in complex with roscovitine and derivatives.
Tang L; Li MH; Cao P; Wang F; Chang WR; Bach S; Reinhardt J; Ferandin Y; Galons H; Wan Y; Gray N; Meijer L; Jiang T; Liang DC
J Biol Chem; 2005 Sep; 280(35):31220-9. PubMed ID: 15985434
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.
Meijer L; Borgne A; Mulner O; Chong JP; Blow JJ; Inagaki N; Inagaki M; Delcros JG; Moulinoux JP
Eur J Biochem; 1997 Jan; 243(1-2):527-36. PubMed ID: 9030781
[TBL] [Abstract][Full Text] [Related]
4. N-&-N, a new class of cell death-inducing kinase inhibitors derived from the purine roscovitine.
Bettayeb K; Sallam H; Ferandin Y; Popowycz F; Fournet G; Hassan M; Echalier A; Bernard P; Endicott J; Joseph B; Meijer L
Mol Cancer Ther; 2008 Sep; 7(9):2713-24. PubMed ID: 18790752
[TBL] [Abstract][Full Text] [Related]
5. Molecular model of cyclin-dependent kinase 5 complexed with roscovitine.
Filgueira de Azevedo W; Gaspar RT; Canduri F; Camera JC; Freitas da Silveira NJ
Biochem Biophys Res Commun; 2002 Oct; 297(5):1154-8. PubMed ID: 12372407
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine.
De Azevedo WF; Leclerc S; Meijer L; Havlicek L; Strnad M; Kim SH
Eur J Biochem; 1997 Jan; 243(1-2):518-26. PubMed ID: 9030780
[TBL] [Abstract][Full Text] [Related]
7. The Cyclin-dependent kinase inhibitor CYC202 (R-roscovitine) inhibits retinoblastoma protein phosphorylation, causes loss of Cyclin D1, and activates the mitogen-activated protein kinase pathway.
Whittaker SR; Walton MI; Garrett MD; Workman P
Cancer Res; 2004 Jan; 64(1):262-72. PubMed ID: 14729633
[TBL] [Abstract][Full Text] [Related]
8. CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases.
Bettayeb K; Oumata N; Echalier A; Ferandin Y; Endicott JA; Galons H; Meijer L
Oncogene; 2008 Oct; 27(44):5797-807. PubMed ID: 18574471
[TBL] [Abstract][Full Text] [Related]
9. Casein kinase 1ε and 1α as novel players in polycystic kidney disease and mechanistic targets for (R)-roscovitine and (S)-CR8.
Billot K; Coquil C; Villiers B; Josselin-Foll B; Desban N; Delehouzé C; Oumata N; Le Meur Y; Boletta A; Weimbs T; Grosch M; Witzgall R; Saunier S; Fischer E; Pontoglio M; Fautrel A; Mrug M; Wallace D; Tran PV; Trudel M; Bukanov N; Ibraghimov-Beskrovnaya O; Meijer L
Am J Physiol Renal Physiol; 2018 Jul; 315(1):F57-F73. PubMed ID: 29537311
[TBL] [Abstract][Full Text] [Related]
10. Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with Roscovitine, a novel cyclin-dependent kinase antagonist.
Pippin JW; Qu Q; Meijer L; Shankland SJ
J Clin Invest; 1997 Nov; 100(10):2512-20. PubMed ID: 9366565
[TBL] [Abstract][Full Text] [Related]
11. Off-target decoding of a multitarget kinase inhibitor by chemical proteomics.
Missner E; Bahr I; Badock V; Lücking U; Siemeister G; Donner P
Chembiochem; 2009 May; 10(7):1163-74. PubMed ID: 19350611
[TBL] [Abstract][Full Text] [Related]
12. Pyrazolo[4,3-d]pyrimidine bioisostere of roscovitine: evaluation of a novel selective inhibitor of cyclin-dependent kinases with antiproliferative activity.
Jorda R; Havlícek L; McNae IW; Walkinshaw MD; Voller J; Sturc A; Navrátilová J; Kuzma M; Mistrík M; Bártek J; Strnad M; Krystof V
J Med Chem; 2011 Apr; 54(8):2980-93. PubMed ID: 21417417
[TBL] [Abstract][Full Text] [Related]
13. Different mechanisms of CDK5 and CDK2 activation as revealed by CDK5/p25 and CDK2/cyclin A dynamics.
Otyepka M; Bártová I; Kríz Z; Koca J
J Biol Chem; 2006 Mar; 281(11):7271-81. PubMed ID: 16407256
[TBL] [Abstract][Full Text] [Related]
14. Several human cyclin-dependent kinase inhibitors, structurally related to roscovitine, are new anti-malarial agents.
Houzé S; Hoang NT; Lozach O; Le Bras J; Meijer L; Galons H; Demange L
Molecules; 2014 Sep; 19(9):15237-57. PubMed ID: 25251193
[TBL] [Abstract][Full Text] [Related]
15. ATP-site directed inhibitors of cyclin-dependent kinases.
Gray N; Détivaud L; Doerig C; Meijer L
Curr Med Chem; 1999 Sep; 6(9):859-75. PubMed ID: 10495356
[TBL] [Abstract][Full Text] [Related]
16. Roscovitine and other purines as kinase inhibitors. From starfish oocytes to clinical trials.
Meijer L; Raymond E
Acc Chem Res; 2003 Jun; 36(6):417-25. PubMed ID: 12809528
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis of differential selectivity of cyclobutyl-substituted imidazole inhibitors against CDKs: insights for rational drug design.
Rath SL; Senapati S
PLoS One; 2013; 8(9):e73836. PubMed ID: 24058495
[TBL] [Abstract][Full Text] [Related]
18. Pyridoxal kinase inhibition by artemisinins down-regulates inhibitory neurotransmission.
Kasaragod VB; Pacios-Michelena A; Schaefer N; Zheng F; Bader N; Alzheimer C; Villmann C; Schindelin H
Proc Natl Acad Sci U S A; 2020 Dec; 117(52):33235-33245. PubMed ID: 33318193
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus-mediated E2F-1 gene transfer induces an apoptotic response in human gastric carcinoma cells that is enhanced by cyclin dependent kinase inhibitors.
Atienza C; Elliott MJ; Dong YB; Yang HL; Stilwell A; Liu TJ; McMasters KM
Int J Mol Med; 2000 Jul; 6(1):55-63. PubMed ID: 10851267
[TBL] [Abstract][Full Text] [Related]
20. Effects of the cyclin-dependent kinase inhibitor R-roscovitine on eosinophil survival and clearance.
Farahi N; Uller L; Juss JK; Langton AJ; Cowburn AS; Gibson A; Foster MR; Farrow SN; Marco-Casanova P; Sobolewski A; Condliffe AM; Chilvers ER
Clin Exp Allergy; 2011 May; 41(5):673-87. PubMed ID: 21255143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
